sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Fibrinogen Market, 2020-2026

Global Fibrinogen Market, 2020-2026

Home / Categories / Other
Global Fibrinogen Market, 2020-2026
Global Fibrinogen Market, 2020-2026
Report Code
RO13/136/2287

Publish Date
25/Jul/2022

Pages
200
PRICE
$ 3950/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5250/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 6400/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Fibrinogen (factor I) is a soluble plasma glycoprotein with a molecular weight of about 340 kDa. The native molecule is a dimer and consists of three pairs of polypeptide chains (A?, B? and ?). Fibrinogen finds application in the treatment of fibrinogen deficiencies and control of bleeding during surgeries. According to Gen Consulting Company, global fibrinogen market is expected to reach USD 1,935.8 million by the end of 2026, expanding at a CAGR of 6.11% over the forecast period i.e. 20202026. Growing potential for fibrinogen in haemostatic therapy sector is the chief contributor for the growth of the market.

The fibrinogen market is segmented on the basis of application, and region. By application, the fibrinogen market is classified into Haemostatic Therapy, Research Use. On the basis of region, the fibrinogen industry is analyzed across North America, Europe, AsiaPacific, South America and MEA (the Middle East, and Africa).

By Application:
Haemostatic Therapy
Research Use

By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.
North America (U.S., Canada, Mexico, etc.)
AsiaPacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)

The market research report covers the analysis of key stake holders of the fibrinogen market. Some of the leading players profiled in the report include:
Baxter International Inc.
CSL Behring LLC
Green Cross Corporation
Harbin Pacific Biopharmaceutical Co., Ltd.
Hualan Biological Engineering Inc.
Jiangxi Boya BioPharmaceutical Co., Ltd.
Johnson & Johnson (Ethicon, Inc.)
LFB S.A.
ProFibrix BV (The Medicines Company)
Shanghai RAAS Blood Products Co., Ltd.
Shanghai Xinxing Medicine Co., Ltd.
*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective
To analyze and forecast the market size of global fibrinogen market.
To classify and forecast global fibrinogen market based on application, and region.
To identify drivers and challenges for global fibrinogen market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global fibrinogen market.
To conduct pricing analysis for global fibrinogen market.
To identify and analyze the profile of leading players operating in global fibrinogen market.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:
Manufacturers of fibrinogen
Raw material suppliers
Market research and consulting firms
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to fibrinogen

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com